Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5451]

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell...

Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology...

Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma ( Dr Todd Michael Bauer - Sarah Cannon Research Institute and Tennessee Oncology, Nashville, USA )

New tools that can be used in clinical practice to make better decisions for...

Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium

New tools that can be used in clinical practice to make better decisions for women with early breast cancer ( Prof Martine Piccart - Université Libre de Bruxelles, Brussels, Belgium )

SEMS trial: result of a prospective, multi-institutional phase II clinical...

Dr Sia Daneshmand - University of Southern California, Los Angeles, USA

SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma ( Dr Sia Daneshmand - University of Southern California, Los Angeles, USA )

Sequencing endocrine treatment in metastatic luminal breast cancer and...

Prof Hope Rugo - University of California San Francisco, San Francisco, USA

Sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment of metastatic BC ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )

Challenges in nursing GU cancer patients during COVID-19

Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK

Challenges in nursing GU cancer patients during COVID-19 ( Louisa Fleure - Guy's and St Thomas' NHS Trust, London, UK )

Latest developments in the treatment of mRCC

Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald

Latest developments in the treatment of mRCC ( Prof Javier Puente, Prof Jens Bedke, Prof James Larkin and Prof Viktor Grünwald )

Long term response to apalutamide and other updates impacting patients with...

Prof Axel Merseburger and Prof Matthew Smith

Long term response to apalutamide and other updates impacting patients with nmCRPC from ASCO GU 2021 ( Prof Axel Merseburger and Prof Matthew Smith )

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early...

Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt...

mCRPC and nmCRPC: Combinations and latest data, what does COVID mean for early treatment? ( Dr Eleni Efstathiou, Prof Stefan Oudard Prof Boris Hadaschik and Prof Gerhardt Attard )

Re-irradiation in breast cancer

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Re-irradiation in breast cancer ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Postmastectomy radiation therapy in breast cancer patients who had immediate...

Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium

Postmastectomy radiation therapy in breast cancer patients who had immediate reconstruction ( Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium )

Current treatment standards for primary ovarian cancer

Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA

Current treatment standards for primary ovarian cancer ( Prof Robert Coleman - MD Anderson Cancer Center, Houston, USA )

Diagnosis, testing and biomarkers in the individualisation of patient care with...

Prof Andrea Necchi and Prof Eva Compérat

Diagnosis, testing and biomarkers in the individualisation of patient care with FGFR mutated bladder cancer ( Prof Andrea Necchi and Prof Eva Compérat )

More from ecancer